Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.86)
# 639
Out of 5,141 analysts
336
Total ratings
41.48%
Success rate
12.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $53.46 | +49.64% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $70.98 | +5.66% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $83.15 | -21.83% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $27.97 | -49.95% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $11.11 | +800.09% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $32.34 | +39.15% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $18.12 | +313.91% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $31.58 | -5.00% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $15.94 | +176.04% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $18.88 | -47.03% | 16 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $21.40 | -53.27% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $12.64 | +137.34% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $9.34 | +1,238.33% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $14.21 | +5.56% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.16 | +331.03% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $7.68 | -34.90% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $5.43 | -7.92% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $6.29 | +138.47% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $17.64 | +155.10% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $1.79 | +67.60% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.93 | +477.20% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.06 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.46 | +379.45% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $6.20 | -51.61% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.06 | -2.91% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.29 | +597.67% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.26 | +185.17% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4,520,000 → $1,723,250 | $0.51 | +339,824,392.21% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.59 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $53.46
Upside: +49.64%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $70.98
Upside: +5.66%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $83.15
Upside: -21.83%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $27.97
Upside: -49.95%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $11.11
Upside: +800.09%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $32.34
Upside: +39.15%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $18.12
Upside: +313.91%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $31.58
Upside: -5.00%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $15.94
Upside: +176.04%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $18.88
Upside: -47.03%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $21.40
Upside: -53.27%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $12.64
Upside: +137.34%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $9.34
Upside: +1,238.33%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $14.21
Upside: +5.56%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.16
Upside: +331.03%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $7.68
Upside: -34.90%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $5.43
Upside: -7.92%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $6.29
Upside: +138.47%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $17.64
Upside: +155.10%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $1.79
Upside: +67.60%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $6.93
Upside: +477.20%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $5.06
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.46
Upside: +379.45%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $6.20
Upside: -51.61%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.06
Upside: -2.91%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.29
Upside: +597.67%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.26
Upside: +185.17%
Sep 6, 2023
Maintains: Buy
Price Target: $4,520,000 → $1,723,250
Current: $0.51
Upside: +339,824,392.21%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $2.59
Upside: -